Jiangsu Hillgene Biopharmaceutical Co., Ltd.
PrivateCompany Overview
Jiangsu Hillgene Biopharmaceutical Co., Ltd. is a biotechnology company that provides comprehensive Cell and Gene Therapy Contract Development and Manufacturing Organization (CQDMO) services for cell therapy products.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clinical Trials, Drug Discovery, Quality Management
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Jiangsu Hillgene Biopharmaceutical Co., Ltd. Comparables
Compare Jiangsu Hillgene Biopharmaceutical Co., Ltd. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| uBriGene Biosciences | 86% | |
| CoJourney | 83% | |
| OBiO Technology | 81% | |
Jiangsu Hillgene Biopharmaceutical Co., Ltd. Funding Rounds
Historical fundraising activity
Market signals
Structured signals derived from secondary market and firmographic data.
- Feb 6, 2025
Grew 21% QoQ from 14 to 17 employees.
- Jan 14, 2025
Grew 100% QoQ, from 9 to 18 employees.
Jiangsu Hillgene Biopharmaceutical Co., Ltd. Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Jiangsu Hillgene Biopharmaceutical Co., Ltd.'s valuation, stock price, and market status.